English
简体中文
Total: £ 56.28
Published Date: 2025-05-02 | Pages: 91 | Tables: 93 | Pharma & Healthcare
The global market for Procalcitonin Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
In China, Procalcitonin Antibody key players include Thermo Fisher, Wondfo , Ningbo Medicalsystem Biotechnology, bioMerieux, Snibe, etc. The top five players hold a share about 35%.
East China is the largest market, with a share about 25%, followed by South China and Southeast China, having a total share about 30 percent.
In terms of product, Monoclonal Procalcitonin Antibody is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital, followed by Medical research institutions, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Procalcitonin Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin Antibody.
The Procalcitonin Antibody market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Procalcitonin Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segment by Application
Hospital
Medical research institutions
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Procalcitonin Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Procalcitonin Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Procalcitonin Antibody Market Overview
1.1 Product Definition
1.2 Procalcitonin Antibody by Type
1.2.1 Global Procalcitonin Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polyclonal Procalcitonin Antibody
1.2.3 Monoclonal Procalcitonin Antibody
1.3 Procalcitonin Antibody by Application
1.3.1 Global Procalcitonin Antibody Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Medical research institutions
1.3.4 Others
1.4 Global Procalcitonin Antibody Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin Antibody Revenue 2020-2031
1.4.2 Global Procalcitonin Antibody Sales 2020-2031
1.4.3 Global Procalcitonin Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Procalcitonin Antibody Market Competition by Manufacturers
2.1 Global Procalcitonin Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Procalcitonin Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Procalcitonin Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Procalcitonin Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Procalcitonin Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Procalcitonin Antibody, Product Type & Application
2.7 Global Key Manufacturers of Procalcitonin Antibody, Date of Enter into This Industry
2.8 Global Procalcitonin Antibody Market Competitive Situation and Trends
2.8.1 Global Procalcitonin Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Procalcitonin Antibody Players Market Share by Revenue
2.8.3 Global Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Procalcitonin Antibody Market Scenario by Region
3.1 Global Procalcitonin Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Procalcitonin Antibody Sales by Region: 2020-2031
3.2.1 Global Procalcitonin Antibody Sales by Region: 2020-2025
3.2.2 Global Procalcitonin Antibody Sales by Region: 2026-2031
3.3 Global Procalcitonin Antibody Revenue by Region: 2020-2031
3.3.1 Global Procalcitonin Antibody Revenue by Region: 2020-2025
3.3.2 Global Procalcitonin Antibody Revenue by Region: 2026-2031
3.4 North America Procalcitonin Antibody Market Facts & Figures by Country
3.4.1 North America Procalcitonin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Procalcitonin Antibody Sales by Country (2020-2031)
3.4.3 North America Procalcitonin Antibody Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Procalcitonin Antibody Market Facts & Figures by Country
3.5.1 Europe Procalcitonin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Procalcitonin Antibody Sales by Country (2020-2031)
3.5.3 Europe Procalcitonin Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procalcitonin Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Procalcitonin Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Procalcitonin Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Procalcitonin Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Procalcitonin Antibody Market Facts & Figures by Country
3.7.1 Latin America Procalcitonin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Procalcitonin Antibody Sales by Country (2020-2031)
3.7.3 Latin America Procalcitonin Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procalcitonin Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Procalcitonin Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Procalcitonin Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Procalcitonin Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Procalcitonin Antibody Sales by Type (2020-2031)
4.1.1 Global Procalcitonin Antibody Sales by Type (2020-2025)
4.1.2 Global Procalcitonin Antibody Sales by Type (2026-2031)
4.1.3 Global Procalcitonin Antibody Sales Market Share by Type (2020-2031)
4.2 Global Procalcitonin Antibody Revenue by Type (2020-2031)
4.2.1 Global Procalcitonin Antibody Revenue by Type (2020-2025)
4.2.2 Global Procalcitonin Antibody Revenue by Type (2026-2031)
4.2.3 Global Procalcitonin Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Procalcitonin Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Procalcitonin Antibody Sales by Application (2020-2031)
5.1.1 Global Procalcitonin Antibody Sales by Application (2020-2025)
5.1.2 Global Procalcitonin Antibody Sales by Application (2026-2031)
5.1.3 Global Procalcitonin Antibody Sales Market Share by Application (2020-2031)
5.2 Global Procalcitonin Antibody Revenue by Application (2020-2031)
5.2.1 Global Procalcitonin Antibody Revenue by Application (2020-2025)
5.2.2 Global Procalcitonin Antibody Revenue by Application (2026-2031)
5.2.3 Global Procalcitonin Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Procalcitonin Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Procalcitonin Antibody Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Company Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Diagnostics Procalcitonin Antibody Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Company Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 bioMerieux Procalcitonin Antibody Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Company Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HyTest Procalcitonin Antibody Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 Wondfo
6.5.1 Wondfo Company Information
6.5.2 Wondfo Description and Business Overview
6.5.3 Wondfo Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wondfo Procalcitonin Antibody Product Portfolio
6.5.5 Wondfo Recent Developments/Updates
6.6 Ningbo Medicalsystem Biotechnology
6.6.1 Ningbo Medicalsystem Biotechnology Company Information
6.6.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product Portfolio
6.6.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.7 Snibe
6.7.1 Snibe Company Information
6.7.2 Snibe Description and Business Overview
6.7.3 Snibe Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Snibe Procalcitonin Antibody Product Portfolio
6.7.5 Snibe Recent Developments/Updates
6.8 Vazyme Biotech
6.8.1 Vazyme Biotech Company Information
6.8.2 Vazyme Biotech Description and Business Overview
6.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vazyme Biotech Procalcitonin Antibody Product Portfolio
6.8.5 Vazyme Biotech Recent Developments/Updates
6.9 Getein Biotech
6.9.1 Getein Biotech Company Information
6.9.2 Getein Biotech Description and Business Overview
6.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Getein Biotech Procalcitonin Antibody Product Portfolio
6.9.5 Getein Biotech Recent Developments/Updates
6.10 Hotgen Biotech
6.10.1 Hotgen Biotech Company Information
6.10.2 Hotgen Biotech Description and Business Overview
6.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hotgen Biotech Procalcitonin Antibody Product Portfolio
6.10.5 Hotgen Biotech Recent Developments/Updates
6.11 Lumigenex
6.11.1 Lumigenex Company Information
6.11.2 Lumigenex Description and Business Overview
6.11.3 Lumigenex Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lumigenex Procalcitonin Antibody Product Portfolio
6.11.5 Lumigenex Recent Developments/Updates
6.12 Shanghai Medicine'nest Pharmaceutical
6.12.1 Shanghai Medicine'nest Pharmaceutical Company Information
6.12.2 Shanghai Medicine'nest Pharmaceutical Description and Business Overview
6.12.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product Portfolio
6.12.5 Shanghai Medicine'nest Pharmaceutical Recent Developments/Updates
6.13 Kitgen
6.13.1 Kitgen Company Information
6.13.2 Kitgen Description and Business Overview
6.13.3 Kitgen Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Kitgen Procalcitonin Antibody Product Portfolio
6.13.5 Kitgen Recent Developments/Updates
6.14 Beijing KeyGen
6.14.1 Beijing KeyGen Company Information
6.14.2 Beijing KeyGen Description and Business Overview
6.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Beijing KeyGen Procalcitonin Antibody Product Portfolio
6.14.5 Beijing KeyGen Recent Developments/Updates
6.15 Fantibody
6.15.1 Fantibody Company Information
6.15.2 Fantibody Description and Business Overview
6.15.3 Fantibody Procalcitonin Antibody Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Fantibody Procalcitonin Antibody Product Portfolio
6.15.5 Fantibody Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procalcitonin Antibody Industry Chain Analysis
7.2 Procalcitonin Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procalcitonin Antibody Production Mode & Process Analysis
7.4 Procalcitonin Antibody Sales and Marketing
7.4.1 Procalcitonin Antibody Sales Channels
7.4.2 Procalcitonin Antibody Distributors
7.5 Procalcitonin Antibody Customer Analysis
8 Procalcitonin Antibody Market Dynamics
8.1 Procalcitonin Antibody Industry Trends
8.2 Procalcitonin Antibody Market Drivers
8.3 Procalcitonin Antibody Market Challenges
8.4 Procalcitonin Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Procalcitonin Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Procalcitonin Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Procalcitonin Antibody Market Competitive Situation by Manufacturers in 2024
Table 4. Global Procalcitonin Antibody Sales (mg) of Key Manufacturers (2020-2025)
Table 5. Global Procalcitonin Antibody Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Procalcitonin Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Procalcitonin Antibody Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Procalcitonin Antibody Average Price (USD/mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Procalcitonin Antibody, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Procalcitonin Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Procalcitonin Antibody, Product Type & Application
Table 12. Global Key Manufacturers of Procalcitonin Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Procalcitonin Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin Antibody as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Procalcitonin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Procalcitonin Antibody Sales by Region (2020-2025) & (mg)
Table 18. Global Procalcitonin Antibody Sales Market Share by Region (2020-2025)
Table 19. Global Procalcitonin Antibody Sales by Region (2026-2031) & (mg)
Table 20. Global Procalcitonin Antibody Sales Market Share by Region (2026-2031)
Table 21. Global Procalcitonin Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Procalcitonin Antibody Revenue Market Share by Region (2020-2025)
Table 23. Global Procalcitonin Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Procalcitonin Antibody Revenue Market Share by Region (2026-2031)
Table 25. North America Procalcitonin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Procalcitonin Antibody Sales by Country (2020-2025) & (mg)
Table 27. North America Procalcitonin Antibody Sales by Country (2026-2031) & (mg)
Table 28. North America Procalcitonin Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Procalcitonin Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Procalcitonin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Procalcitonin Antibody Sales by Country (2020-2025) & (mg)
Table 32. Europe Procalcitonin Antibody Sales by Country (2026-2031) & (mg)
Table 33. Europe Procalcitonin Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Procalcitonin Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Procalcitonin Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Procalcitonin Antibody Sales by Region (2020-2025) & (mg)
Table 37. Asia Pacific Procalcitonin Antibody Sales by Region (2026-2031) & (mg)
Table 38. Asia Pacific Procalcitonin Antibody Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Procalcitonin Antibody Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Procalcitonin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Procalcitonin Antibody Sales by Country (2020-2025) & (mg)
Table 42. Latin America Procalcitonin Antibody Sales by Country (2026-2031) & (mg)
Table 43. Latin America Procalcitonin Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Procalcitonin Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Procalcitonin Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Procalcitonin Antibody Sales by Country (2020-2025) & (mg)
Table 47. Middle East and Africa Procalcitonin Antibody Sales by Country (2026-2031) & (mg)
Table 48. Middle East and Africa Procalcitonin Antibody Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Procalcitonin Antibody Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Procalcitonin Antibody Sales (mg) by Type (2020-2025)
Table 51. Global Procalcitonin Antibody Sales (mg) by Type (2026-2031)
Table 52. Global Procalcitonin Antibody Sales Market Share by Type (2020-2025)
Table 53. Global Procalcitonin Antibody Sales Market Share by Type (2026-2031)
Table 54. Global Procalcitonin Antibody Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Procalcitonin Antibody Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Procalcitonin Antibody Revenue Market Share by Type (2020-2025)
Table 57. Global Procalcitonin Antibody Revenue Market Share by Type (2026-2031)
Table 58. Global Procalcitonin Antibody Price (USD/mg) by Type (2020-2025)
Table 59. Global Procalcitonin Antibody Price (USD/mg) by Type (2026-2031)
Table 60. Global Procalcitonin Antibody Sales (mg) by Application (2020-2025)
Table 61. Global Procalcitonin Antibody Sales (mg) by Application (2026-2031)
Table 62. Global Procalcitonin Antibody Sales Market Share by Application (2020-2025)
Table 63. Global Procalcitonin Antibody Sales Market Share by Application (2026-2031)
Table 64. Global Procalcitonin Antibody Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Procalcitonin Antibody Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Procalcitonin Antibody Revenue Market Share by Application (2020-2025)
Table 67. Global Procalcitonin Antibody Revenue Market Share by Application (2026-2031)
Table 68. Global Procalcitonin Antibody Price (USD/mg) by Application (2020-2025)
Table 69. Global Procalcitonin Antibody Price (USD/mg) by Application (2026-2031)
Table 70. Thermo Fisher Company Information
Table 71. Thermo Fisher Description and Business Overview
Table 72. Thermo Fisher Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 73. Thermo Fisher Procalcitonin Antibody Product
Table 74. Thermo Fisher Recent Developments/Updates
Table 75. Roche Diagnostics Company Information
Table 76. Roche Diagnostics Description and Business Overview
Table 77. Roche Diagnostics Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 78. Roche Diagnostics Procalcitonin Antibody Product
Table 79. Roche Diagnostics Recent Developments/Updates
Table 80. bioMerieux Company Information
Table 81. bioMerieux Description and Business Overview
Table 82. bioMerieux Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 83. bioMerieux Procalcitonin Antibody Product
Table 84. bioMerieux Recent Developments/Updates
Table 85. HyTest Company Information
Table 86. HyTest Description and Business Overview
Table 87. HyTest Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 88. HyTest Procalcitonin Antibody Product
Table 89. HyTest Recent Developments/Updates
Table 90. Wondfo Company Information
Table 91. Wondfo Description and Business Overview
Table 92. Wondfo Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 93. Wondfo Procalcitonin Antibody Product
Table 94. Wondfo Recent Developments/Updates
Table 95. Ningbo Medicalsystem Biotechnology Company Information
Table 96. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 97. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 98. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product
Table 99. Ningbo Medicalsystem Biotechnology Recent Developments/Updates
Table 100. Snibe Company Information
Table 101. Snibe Description and Business Overview
Table 102. Snibe Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 103. Snibe Procalcitonin Antibody Product
Table 104. Snibe Recent Developments/Updates
Table 105. Vazyme Biotech Company Information
Table 106. Vazyme Biotech Description and Business Overview
Table 107. Vazyme Biotech Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 108. Vazyme Biotech Procalcitonin Antibody Product
Table 109. Vazyme Biotech Recent Developments/Updates
Table 110. Getein Biotech Company Information
Table 111. Getein Biotech Description and Business Overview
Table 112. Getein Biotech Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 113. Getein Biotech Procalcitonin Antibody Product
Table 114. Getein Biotech Recent Developments/Updates
Table 115. Hotgen Biotech Company Information
Table 116. Hotgen Biotech Description and Business Overview
Table 117. Hotgen Biotech Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 118. Hotgen Biotech Procalcitonin Antibody Product
Table 119. Hotgen Biotech Recent Developments/Updates
Table 120. Lumigenex Company Information
Table 121. Lumigenex Description and Business Overview
Table 122. Lumigenex Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 123. Lumigenex Procalcitonin Antibody Product
Table 124. Lumigenex Recent Developments/Updates
Table 125. Shanghai Medicine'nest Pharmaceutical Company Information
Table 126. Shanghai Medicine'nest Pharmaceutical Description and Business Overview
Table 127. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 128. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product
Table 129. Shanghai Medicine'nest Pharmaceutical Recent Developments/Updates
Table 130. Kitgen Company Information
Table 131. Kitgen Description and Business Overview
Table 132. Kitgen Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 133. Kitgen Procalcitonin Antibody Product
Table 134. Kitgen Recent Developments/Updates
Table 135. Beijing KeyGen Company Information
Table 136. Beijing KeyGen Description and Business Overview
Table 137. Beijing KeyGen Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 138. Beijing KeyGen Procalcitonin Antibody Product
Table 139. Beijing KeyGen Recent Developments/Updates
Table 140. Fantibody Company Information
Table 141. Fantibody Description and Business Overview
Table 142. Fantibody Procalcitonin Antibody Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 143. Fantibody Procalcitonin Antibody Product
Table 144. Fantibody Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Procalcitonin Antibody Distributors List
Table 148. Procalcitonin Antibody Customers List
Table 149. Procalcitonin Antibody Market Trends
Table 150. Procalcitonin Antibody Market Drivers
Table 151. Procalcitonin Antibody Market Challenges
Table 152. Procalcitonin Antibody Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Procalcitonin Antibody
Figure 2. Global Procalcitonin Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Procalcitonin Antibody Market Share by Type: 2024 & 2031
Figure 4. Polyclonal Procalcitonin Antibody Product Picture
Figure 5. Monoclonal Procalcitonin Antibody Product Picture
Figure 6. Global Procalcitonin Antibody Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Procalcitonin Antibody Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Medical research institutions
Figure 10. Others
Figure 11. Global Procalcitonin Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Procalcitonin Antibody Market Size (2020-2031) & (US$ Million)
Figure 13. Global Procalcitonin Antibody Sales (2020-2031) & (mg)
Figure 14. Global Procalcitonin Antibody Average Price (USD/mg) & (2020-2031)
Figure 15. Procalcitonin Antibody Report Years Considered
Figure 16. Procalcitonin Antibody Sales Share by Manufacturers in 2024
Figure 17. Global Procalcitonin Antibody Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Procalcitonin Antibody Players: Market Share by Revenue in Procalcitonin Antibody in 2024
Figure 19. Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Procalcitonin Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Procalcitonin Antibody Sales Market Share by Country (2020-2031)
Figure 22. North America Procalcitonin Antibody Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Procalcitonin Antibody Sales Market Share by Country (2020-2031)
Figure 26. Europe Procalcitonin Antibody Revenue Market Share by Country (2020-2031)
Figure 27. Germany Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Procalcitonin Antibody Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Procalcitonin Antibody Revenue Market Share by Region (2020-2031)
Figure 34. China Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Procalcitonin Antibody Sales Market Share by Country (2020-2031)
Figure 44. Latin America Procalcitonin Antibody Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Procalcitonin Antibody Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Procalcitonin Antibody Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Procalcitonin Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Procalcitonin Antibody by Type (2020-2031)
Figure 54. Global Revenue Market Share of Procalcitonin Antibody by Type (2020-2031)
Figure 55. Global Procalcitonin Antibody Price (USD/mg) by Type (2020-2031)
Figure 56. Global Sales Market Share of Procalcitonin Antibody by Application (2020-2031)
Figure 57. Global Revenue Market Share of Procalcitonin Antibody by Application (2020-2031)
Figure 58. Global Procalcitonin Antibody Price (USD/mg) by Application (2020-2031)
Figure 59. Procalcitonin Antibody Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
